उत्पाद विवरण
Carfilnat 60 mg Injection is a potent medication classified as a protease inhibitor, specifically designed for the management of multiple myeloma, a cancer that affects plasma cells in the blood. By inhibiting the activity of protease enzymes, Carfilnat disrupts the cancer cell lifecycle, effectively halting their growth and proliferation. This targeted action not only helps in controlling the disease but also enhances the overall treatment regimen for patients battling this challenging condition. It is essential for users to be aware of potential side effects, including fatigue and gastrointestinal disturbances, which may occur during treatment. Before starting Carfilnat, patients should discuss their medical history with a healthcare provider, especially if they have liver issues or are taking other medications, to avoid adverse interactions. With its innovative mechanism of action, Carfilnat represents a significant advancement in multiple myeloma therapy, offering hope to many patients. Always consult with a healthcare professional for personalized advice and to ensure the best outcomes during your treatment journey.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese